Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Archiv. 2005;447(5):794–9.

Article  PubMed  Google Scholar 

Adsay NV, Pierson C, Sarkar F, Abrams J, Weaver D, Conlon KC, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol. 2001;25:26.

Article  CAS  PubMed  Google Scholar 

Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms delineation of an “intestinal” pathway of carcinogenesis in the pancreas [Internet]. 2004. Available from: http://journals.lww.com/ajsp

Khalil L, Huang Z, Zakka K, Jiang R, Penley M, Alese OB, et al. Survival and prognostic factors in patients with pancreatic colloid carcinoma compared with pancreatic ductal adenocarcinoma. Pancreas. 2023;52(1):E75-84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Modern Pathol. 2002;15(10):1087–95.

Article  Google Scholar 

Mino-Kenudson M, Fernández-del Castillo C, Baba Y, Valsangkar NP, Liss AS, Hsu M, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60(12):1712–20.

Article  PubMed  PubMed Central  Google Scholar 

Lange F. Der Gallertkrebs der Brustdrüse. Beiträge zur klinischen Chirurgie. 1896;16:1–60.

Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathol Blackwell Publ Ltd. 2020;76:182–8.

Google Scholar 

Adsay NV, Merati K, Shia J, Sarkar F, Pierson CR, Cheng JD, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. 2003.

Lu Q, Zhou H, Zhang J, Lee K, Chen L, Hong R, et al. Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer. Breast. 2024;76:103760.

Article  PubMed  PubMed Central  Google Scholar 

Elomaa H, Tarkiainen V, Äijälä VK, Sirniö P, Ahtiainen M, Sirkiä O, et al. Associations of mucinous differentiation and mucin expression with immune cell infiltration and prognosis in colorectal adenocarcinoma: molecular diagnostics. Br J Cancer. 2025;132(7):660–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, Chen JH, Yiannoutsos CT, Lillemoe KD, et al. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American joint committee on cancer stage. J Am Coll Surg. 2011;213(2):275–83.

Article  PubMed  Google Scholar 

Yamada S, Fujii T, Shimoyama Y, Kanda M, Nakayama G, Sugimoto H, et al. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm. Ann Surg Oncol. 2014;21(7):2444–52.

Article  PubMed  Google Scholar 

Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251(3):470–6.

Article  PubMed  PubMed Central  Google Scholar 

Nakata K, Ohuchida K, Aishima S, Sadakari Y, Kayashima T, Miyasaka Y, et al. Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis [Internet]. 2011. Available from: www.pancreasjournal.com

Habib JR, Hidalgo Salinas C, Berger NF, Rompen IF, Campbell BA, Kinny-Köster B, et al. Incidence and outcomes of intraductal oncocytic papillary neoplasm-derived pancreatic cancer compared with tubular and colloid intraductal papillary mucinous neoplasm-derived pancreatic cancer: an international multicenter retrospective study. Ann Surg Oncol. 2025;32(10):7433–42.

Article  PubMed  Google Scholar 

Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60(4):509–16.

Article  PubMed  Google Scholar 

Ohtsuka T, Fernandez-del Castillo C, Furukawa T, Hijioka S, Jang JY, Lennon AM, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24:255–70.

Article  CAS  PubMed  Google Scholar 

Escalon JG, Gerst S, Porembka M, Allen PJ, Do RKG. Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT. Clin Imaging. 2016;40(6):1195–9.

Article  PubMed  PubMed Central  Google Scholar 

Fouladi DF, Raman SP, Hruban RH, Fishman EK, Kawamoto S. Invasive intraductal papillary mucinous neoplasms: CT features of colloid carcinoma versus tubular adenocarcinoma of the pancreas. Am J Roentgenol. 2020;214(5):1092–100.

Article  Google Scholar 

Margonis GA, Pulvirenti A, Morales-Oyarvide V, Buettner S, Andreatos N, Kamphues C, et al. Performance of the 7th and 8th editions of the american joint committee on cancer staging system in patients with intraductal papillary mucinous neoplasm-associated PDAC: a multi-institutional analysis. Ann Surg. 2023;277(4):681–8.

Article  PubMed  Google Scholar 

Wang X, Fang S, Shen Y, Luo J, Liu H, Zhao D, et al. Original Article The clinical characteristics of pancreatic colloid carcinoma and the development and validation of its cancer-specific survival prediction nomogram. Gland Surg. 2023;12(3):386–401.

Article  PubMed  PubMed Central  Google Scholar 

Seidel G, Zahurak M, Iacobuzio-Donahue C, Sohn TA, Adsay NV, Yeo CJ, et al. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms a study of 39 cases. Am J Surg Pathol. 2002;26:56.

Article  PubMed  Google Scholar 

Liszka Ł, Zielińska-Pajak E, Pajak J, Gołka D. Colloid carcinoma of the pancreas: review of selected pathological and clinical aspects. Pathology. 2008;40(7):655–63.

Article  CAS  PubMed  Google Scholar 

Lucocq J, Haugk B, Parkinson D, Darne A, Joseph N, Hawkyard J, et al. Precursor epithelial subtypes of adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN): clinicopathological features, recurrence and response to adjuvant chemotherapy. Ann Surg Oncol. 2024;31(10):7023–32.

Article  PubMed  PubMed Central  Google Scholar 

Habib JR, Rompen IF, Javed AA, Campbell BA, Kinny-Köster B, Tan PH, Miller RM, Pellegrini R, Marchetti A, Andel PCM, Perri G, Lafaro KJ, Hewitt DB, Kaiser J, Daamen LA, Hank T, Sacks GD, Billeter AT, Morgan K, & Busch OR. Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer. Annals of Surgery 2025. https://doi.org/10.1097/sla.0000000000006687

Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303.

Article  PubMed  Google Scholar 

Raynaud CM, Jabeen A, Ahmed EI, Hubrack S, Sanchez A, Sherif S, et al. MUC2 expression modulates immune infiltration in colorectal cancer. Front Immunol. 2024;15:1500374.

Article  CAS  PubMed  Google Scholar